U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 397

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr22:17700244
GRCh38:
Chr22:17219354
ADA2Vasculitis due to ADA2 deficiencyLikely pathogenic
(May 2, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr22:17684636
GRCh38:
Chr22:17203746
ADA2Vasculitis due to ADA2 deficiency, Sneddon syndromeLikely benign
(Apr 29, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr22:17669320
GRCh38:
Chr22:17188430
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Apr 18, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr22:17662373-17672720
ADA2Vasculitis due to ADA2 deficiencyUncertain significance
(Aug 19, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr22:17684433-17690567
ADA2Vasculitis due to ADA2 deficiencyUncertain significance
(Jul 11, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr22:17669209-17672720
ADA2Vasculitis due to ADA2 deficiencyPathogenic
(Jul 12, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr22:17565982-20052185
Immunodeficiency 51, Vasculitis due to ADA2 deficiencyPathogenic
(Apr 17, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr22:17662838-17662839
GRCh38:
Chr22:17181948-17181949
ADA2I197K, I318K, I396K, I438KVasculitis due to ADA2 deficiencyUncertain significance
(Dec 9, 2021)
criteria provided, single submitter
9.
GRCh37:
Chr22:17690541
GRCh38:
Chr22:17209651
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Jun 8, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr22:17684479
GRCh38:
Chr22:17203589
ADA2M123V, M201V, M243VVasculitis due to ADA2 deficiencyUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr22:17662886
GRCh38:
Chr22:17181996
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Apr 24, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr22:17684546
GRCh38:
Chr22:17203656
ADA2Y100*, Y178*, Y220*Vasculitis due to ADA2 deficiencyPathogenic
(Sep 30, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr22:17670843
GRCh38:
Chr22:17189953
ADA2G279R, G321R, G201R, G80RVasculitis due to ADA2 deficiencyUncertain significance
(Aug 20, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr22:17672638
GRCh38:
Chr22:17191748
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Jul 23, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr22:17670823
GRCh38:
Chr22:17189933
ADA2Vasculitis due to ADA2 deficiencyBenign
(Oct 26, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr22:17684566
GRCh38:
Chr22:17203676
ADA2I172V, I214V, I94VVasculitis due to ADA2 deficiencyUncertain significance
(Jan 26, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr22:17662900
GRCh38:
Chr22:17182010
ADA2V376L, V177L, V298L, V418LVasculitis due to ADA2 deficiencyUncertain significance
(Apr 1, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr22:17688046
GRCh38:
Chr22:17207156
ADA2P153S, P33S, P111SVasculitis due to ADA2 deficiencyUncertain significance
(Feb 23, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr22:17688174
GRCh38:
Chr22:17207284
ADA2A110V, A68VVasculitis due to ADA2 deficiencyUncertain significance
(Jan 19, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr22:17662707
GRCh38:
Chr22:17181817
ADA2Vasculitis due to ADA2 deficiencyUncertain significance
(May 20, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr22:17687957
GRCh38:
Chr22:17207067
ADA2Vasculitis due to ADA2 deficiencyUncertain significance
(Aug 3, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr22:17690270
GRCh38:
Chr22:17209380
ADA2N100Y, N58YVasculitis due to ADA2 deficiencyUncertain significance
(Jul 23, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr22:17688057
GRCh38:
Chr22:17207167
ADA2A29V, A107V, A149VVasculitis due to ADA2 deficiencyUncertain significance
(Mar 4, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr22:17662454
GRCh38:
Chr22:17181564
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Apr 26, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr22:17688148
GRCh38:
Chr22:17207258
ADA2V119M, V77MVasculitis due to ADA2 deficiencyUncertain significance
(Jun 15, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr22:17688142
GRCh38:
Chr22:17207252
ADA2M79V, M121V, M1VVasculitis due to ADA2 deficiencyUncertain significance
(Oct 31, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr22:17690397
GRCh38:
Chr22:17209507
ADA2E57D, E15DVasculitis due to ADA2 deficiencyUncertain significance
(Jul 15, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr22:17688088
GRCh38:
Chr22:17207198
ADA2T139A, T19A, T97AVasculitis due to ADA2 deficiencyUncertain significance
(Sep 9, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr22:17688166
GRCh38:
Chr22:17207276
ADA2L71I, L113IVasculitis due to ADA2 deficiencyUncertain significance
(Aug 2, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr22:17669344
GRCh38:
Chr22:17188454
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Aug 31, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr22:17670900
GRCh38:
Chr22:17190010
ADA2A182T, A260T, A302T, A61TVasculitis due to ADA2 deficiencyUncertain significance
(Mar 4, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr22:17688113
GRCh38:
Chr22:17207223
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Aug 21, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr22:17672687
GRCh38:
Chr22:17191797
ADA2S136N, S256N, S15N, S214NVasculitis due to ADA2 deficiencyUncertain significance
(Aug 19, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr22:17672582
GRCh38:
Chr22:17191692
ADA2S171L, S249L, S291L, S50LVasculitis due to ADA2 deficiencyUncertain significance
(Aug 22, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr22:17663629
GRCh38:
Chr22:17182739
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Aug 13, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr22:17690424
GRCh38:
Chr22:17209534
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Jun 10, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr22:17690493
GRCh38:
Chr22:17209603
ADA2Vasculitis due to ADA2 deficiencyUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr22:17670822
GRCh38:
Chr22:17189932
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Apr 4, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr22:17690457
GRCh38:
Chr22:17209567
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Jun 15, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr22:17684641
GRCh38:
Chr22:17203751
ADA2V189L, V69L, V147LVasculitis due to ADA2 deficiencyUncertain significance
(Jun 9, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr22:17672674
GRCh38:
Chr22:17191784
ADA2H19Q, H260Q, H140Q, H218QVasculitis due to ADA2 deficiencyUncertain significance
(Jan 11, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr22:17669335
GRCh38:
Chr22:17188445
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Sep 7, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr22:17662917
GRCh38:
Chr22:17182027
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Sep 25, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr22:17669326
GRCh38:
Chr22:17188436
ADA2E208D, E328D, E87D, E286DVasculitis due to ADA2 deficiencyLikely pathogenic
(Jan 16, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr22:17690315
GRCh38:
Chr22:17209425
ADA2H85D, H43DVasculitis due to ADA2 deficiencyUncertain significance
(May 7, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr22:17669348
GRCh38:
Chr22:17188458
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Mar 26, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr22:17684626
GRCh38:
Chr22:17203736
ADA2E152K, E74K, E194KVasculitis due to ADA2 deficiencyUncertain significance
(Mar 15, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr22:17690400
GRCh38:
Chr22:17209510
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Mar 11, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr22:17669330
GRCh38:
Chr22:17188440
ADA2H327P, H207P, H285P, H86PVasculitis due to ADA2 deficiencyUncertain significance
(Jul 15, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr22:17672604
GRCh38:
Chr22:17191714
ADA2I43L, I164L, I242L, I284LVasculitis due to ADA2 deficiencyUncertain significance
(Feb 22, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr22:17690417
GRCh38:
Chr22:17209527
ADA2V51L, V9LVasculitis due to ADA2 deficiencyUncertain significance
(Aug 15, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr22:17684563
GRCh38:
Chr22:17203673
ADA2S173T, S215T, S95TVasculitis due to ADA2 deficiencyUncertain significance
(Feb 4, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr22:17670824
GRCh38:
Chr22:17189934
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Jul 26, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr22:17684440
GRCh38:
Chr22:17203550
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Jun 12, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr22:17670878
GRCh38:
Chr22:17189988
ADA2M68T, M189T, M267T, M309TVasculitis due to ADA2 deficiencyUncertain significance
(Jul 14, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr22:17688037
GRCh38:
Chr22:17207147
ADA2S114P, S156P, S36PVasculitis due to ADA2 deficiencyUncertain significance
(Feb 22, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr22:17690495
GRCh38:
Chr22:17209605
ADA2G25SVasculitis due to ADA2 deficiencyUncertain significance
(Jul 1, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr22:17690495
GRCh38:
Chr22:17209605
ADA2G25CVasculitis due to ADA2 deficiencyUncertain significance
(Sep 1, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr22:17690318
GRCh38:
Chr22:17209428
ADA2M84V, M42VVasculitis due to ADA2 deficiencyUncertain significance
(Oct 21, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr22:17662698-17662699
GRCh38:
Chr22:17181808-17181809
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Jan 3, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr22:17690470
GRCh38:
Chr22:17209580
ADA2T33IVasculitis due to ADA2 deficiencyUncertain significance
(Feb 17, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr22:17662849
GRCh38:
Chr22:17181959
ADA2P194S, P435S, P393S, P315SVasculitis due to ADA2 deficiencyUncertain significance
(Feb 11, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr22:17684530
GRCh38:
Chr22:17203640
ADA2D226N, D106N, D184NVasculitis due to ADA2 deficiencyUncertain significance
(Dec 20, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr22:17684681
GRCh38:
Chr22:17203791
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Oct 7, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr22:17662457
GRCh38:
Chr22:17181567
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Sep 29, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr22:17662881
GRCh38:
Chr22:17181991
ADA2H183R, H304R, H382R, H424RVasculitis due to ADA2 deficiencyUncertain significance
(Oct 11, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr22:17662484
GRCh38:
Chr22:17181594
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Sep 2, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr22:17672561
GRCh38:
Chr22:17191671
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Aug 31, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr22:17669255
GRCh38:
Chr22:17188365
ADA2P232fs, P352fs, P310fs, P111fsVasculitis due to ADA2 deficiencyPathogenic
(Aug 12, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr22:17669272
GRCh38:
Chr22:17188382
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Oct 7, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr22:17690397
GRCh38:
Chr22:17209507
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Oct 13, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr22:17688164
GRCh38:
Chr22:17207274
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Jun 26, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr22:17690329
GRCh38:
Chr22:17209439
ADA2F38fs, F80fsVasculitis due to ADA2 deficiencyPathogenic
(Sep 16, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr22:17690467
GRCh38:
Chr22:17209577
ADA2R34PVasculitis due to ADA2 deficiencyUncertain significance
(Oct 17, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr22:17688051
GRCh38:
Chr22:17207161
ADA2P151L, P31L, P109LVasculitis due to ADA2 deficiencyUncertain significance
(May 4, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr22:17669213
GRCh38:
Chr22:17188323
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Jun 8, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr22:17663653
GRCh38:
Chr22:17182763
ADA2Vasculitis due to ADA2 deficiencyLikely pathogenic
(Sep 30, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr22:17663510
GRCh38:
Chr22:17182620
ADA2C408S, C366S, C167S, C288SVasculitis due to ADA2 deficiencyUncertain significance
(Jun 19, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr22:17670935
GRCh38:
Chr22:17190045
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Jul 6, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr22:17669249-17669252
GRCh38:
Chr22:17188359-17188362
ADA2Y112fs, Y353fs, Y233fs, Y311fsVasculitis due to ADA2 deficiencyPathogenic
(Jun 12, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr22:17670858
GRCh38:
Chr22:17189968
ADA2P274S, P316S, P196S, P75SVasculitis due to ADA2 deficiencyUncertain significance
(Apr 16, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr22:17670920
GRCh38:
Chr22:17190030
ADA2S175F, S253F, S295F, S54FVasculitis due to ADA2 deficiencyUncertain significance
(May 12, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr22:17670906
GRCh38:
Chr22:17190016
ADA2V180L, V258L, V59L, V300LVasculitis due to ADA2 deficiencyUncertain significance
(May 4, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr22:17663663
GRCh38:
Chr22:17182773
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Sep 7, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr22:17690251
GRCh38:
Chr22:17209361
ADA2P106R, P64RVasculitis due to ADA2 deficiencyUncertain significance
(Feb 25, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr22:17690430-17690431
GRCh38:
Chr22:17209540-17209541
ADA2R7fs, R49fsVasculitis due to ADA2 deficiencyPathogenic
(Jan 22, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr22:17663634
GRCh38:
Chr22:17182744
ADA2I325V, I247V, I367V, I126VVasculitis due to ADA2 deficiencyUncertain significance
(Mar 27, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr22:17662396
GRCh38:
Chr22:17181506
ADA2I385V, I264V, I463V, I505VVasculitis due to ADA2 deficiencyUncertain significance
(Jul 30, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr22:17663524
GRCh38:
Chr22:17182634
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(May 4, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr22:17662436-17662437
GRCh38:
Chr22:17181546-17181547
ADA2N371fs, N449fs, N250fs, N491fsVasculitis due to ADA2 deficiencyLikely pathogenic
(Feb 23, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr22:17669330
GRCh38:
Chr22:17188440
ADA2H327R, H285R, H86R, H207RVasculitis due to ADA2 deficiencyUncertain significance
(Jul 15, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr22:17688188
GRCh38:
Chr22:17207298
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Sep 1, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr22:17684644
GRCh38:
Chr22:17203754
ADA2L146V, L188V, L68VAutoinflammatory syndrome, Vasculitis due to ADA2 deficiency, Sneddon syndrome
Uncertain significance
(Nov 2, 2021)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr22:17662918
GRCh38:
Chr22:17182028
ADA2Vasculitis due to ADA2 deficiency, Autoinflammatory syndromeConflicting interpretations of pathogenicity
(May 24, 2022)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr22:17663520
GRCh38:
Chr22:17182630
ADA2I164L, I285L, I363L, I405LVasculitis due to ADA2 deficiency, Autoinflammatory syndromeUncertain significance
(Jul 2, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr22:17684658
GRCh38:
Chr22:17203768
ADA2L141P, L183P, L63PVasculitis due to ADA2 deficiencyLikely pathogenic
(Jun 21, 2022)
no assertion criteria provided
97.
GRCh37:
Chr22:17663512
GRCh38:
Chr22:17182622
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Mar 16, 2021)
criteria provided, single submitter
98.
GRCh37:
Chr22:17663485
GRCh38:
Chr22:17182595
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(Jul 19, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr22:17663661
GRCh38:
Chr22:17182771
ADA2Vasculitis due to ADA2 deficiency, Sneddon syndrome, Vasculitis due to ADA2 deficiency
Likely benign
(Aug 22, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr22:17672557
GRCh38:
Chr22:17191667
ADA2Vasculitis due to ADA2 deficiencyLikely benign
(May 10, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination